Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
iO Resistant sqNSCLC
Los Angeles, California
iO Resistant sqNSCLC Clinical Trials in Los Angeles, California
1 recruiting
Los Angeles, California
Showing
1–1
of
1
trials
Recruiting
Phase 3
IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed
iO Resistant sqNSCLC
Fortvita Biologics (USA)Inc.
600 enrolled
44 locations
NCT07217301
Feedback